Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome.

H. Hawighorst, W. Weikel, P. G. Knapstein, +5

PubMed

Disease OutcomeTumoral PathologyAngiogenesisCervical CancerOncologic Imaging +12

Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.

H. Hawighorst, P. G. Knapstein, Michael V. Knopp, +7

PubMed

Time-intensity CurvesGynecologyPathologyGliomaGynecology Oncology +20

Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement.

H. Hawighorst, P. G. Knapstein, W. Weikel, +10

PubMed

Tumor InnervationGynecologyPathologyGliomaMagnetic Resonance Imaging +17

Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer

Marcus Schmidt, Dirk Hasenclever, Mitra Schaeffer, +14

Clinical Cancer Research

Tumor Vascularity—A Novel Prognostic Factor in Advanced Cervical Carcinoma

Karlheinz Schlenger, Michael Höckel, M. Mitze, +4

Gynecologic Oncology

Tumoral PathologyCervical CancerMedicineAdvanced Cervical CarcinomaPathology +2

Long-term prognostic significance of HER2-low and HER2-zero in node-negative breast cancer

Katrin Almstedt, Anne-Sophie Heimes, Franziska Kappenberg, +12

European Journal of Cancer

Long-term Prognostic SignificanceBreast OncologyMedicinePathologyBreast Cancer +6

Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015

Schnürch Hg, S. Ackermann, Céline D. Alt, +17

Geburtshilfe und Frauenheilkunde

Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging.

H. Hawighorst, P. G. Knapstein, W. Weikel, +8

Radiology

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations

Shan Wang‐Gohrke, W. Weikel, Harvey A. Risch, +13

British Journal of Cancer

Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67

W. Weikel, Thomas Beck, M. Mitze, +1

Breast Cancer Research and Treatment

Breast OncologyOncologyMedicineImmunologyCancer Growth +8